Keep what works. Expand where it can go.

BioPhase Instrument API

Connect the BioPhase 8800 system into workflows that don’t wait.

As biopharma pipelines move faster, analytical workflows need to scale without losing consistency.

Manual processes and disconnected systems can slow development, introduce variability, and create gaps between stages.

The BioPhase Instrument Application Programming Interface (API) enables integration of the BioPhase 8800 system with existing laboratory automation platforms.

From remote sequence execution and real-time instrument monitoring to allowing workflow orchestration and automated data acquisition, the BioPhase Instrument API helps development teams scale to meet the demands of modern biopharma.

Scale without losing visibility

Automate routine workflow execution

Enable external software platforms to remotely start, monitor, and stop BioPhase 8800 system sequence runs, helping reduce manual intervention and improve workflow consistency.

Monitor and manage instrument operations

Support remote control of key instrument functions, including workflow execution, tray operations, and system status monitoring.

Expand instrument utilization

Support automated and unattended workflows to help maximize throughput and increase operational efficiency.

The BioPhase Instrument API provides programmatic access to key instrument control and sequence execution functions, supporting integration with external software applications and connected laboratory environments.

Capabilities include:

  • Cartridge temperature control
  • Sample storage temperature control
  • Detector control
  • Cartridge management
  • Sample tray operation

The BioPhase Instrument API enables automation platforms to remotely interact with BioPhase 8800 system workflows, which can support more efficient and higher throughput laboratory operations.

Capabilities include:

  • Start sequence acquisition
  • Monitoring of analytical progress
  • Stop sequence execution
  • Allow integration with scheduling, orchestration, and robotic systems
  • Ability to access project and sequence information

Maintain visibility into instrument status and workflow execution through API-enabled monitoring capabilities.

Capabilities include:

  • Instrument readiness and status monitoring
  • Detector status monitoring
  • Sequence and method progress tracking
  • Real-time acquisition monitoring
  • Sample and reagent tray position monitoring
  • Temperature and coolant level monitoring

Related applications

Reclaim time for innovation by identifying and advancing drug candidates more confidently with analytical strategies that support your team across modalities, from discovery to commercialization.

Messenger RNA analysis

Break through barriers and extend the frontiers of mRNA, saRNA, and circRNA development with intuitive analytical solutions. Confidently innovate with high-quality, sensitive, and accurate data to assess integrity, purity, and CQAs.

Learn more
Plasmid and DNA analysis

Advance your projects with purpose-built solutions for the analysis of pDNA and dsDNA to support the development of your mRN), viral vectors, recombinant proteins, and other new modalities.

Learn more
Viral vector characterization

Optimize your processes with solutions that overcome the analytical challenges of viral vector-based drugs. Take control of full and empty ratios and protein and genome profiles. Break down the boundaries of protein and post-translational modification (PTM) characterization with dedicated high-resolution workflows offering unprecedented depth.

Learn more
CRISPR/Cas9 analysis

Set your own schedule for CRISPR/Cas9 gene editing with innovative, intuitive analytical solutions. Unleash the potential of your Cas9 mRNa, sgRNA, and Cas9 proteins by understanding quality, purity, and safety and assessing on/off target effects.

Learn more
Cell line analysis

Set the pace with confidence. Cell line monitoring and analysis solutions verify the identity, purity, and stability of lead candidates with high throughput strategies that are ready for automation.

Learn more
Glycan analysis

Fully understand drug candidate glycoprofiles with pipeline-specific solutions. Gather critical high-resolution information and site-specific data points with advanced glycan analysis for complex biologic development.

Learn more
Charge heterogeneity analysis

Pursue the end goal with confidence. Achieve the full picture and accelerate decisions with comprehensive characterization of biopharmaceutical charge variants.

Learn more
CE-SDS microsite

Discover how CE‑SDS enables quantitative purity assessment, estimation of product‑related impurities, and batch‑to‑batch consistency across the drug development lifecycle—supporting informed decision‑making and delivery of safe, effective therapies.

Learn more

Let's connect.

Stay up-to-date with biopharma conversations on LinkedIn

Frequently asked questions

The BioPhase Instrument API enables integration of the BioPhase 8800 system into laboratory automation workflows, allowing external software applications to remotely monitor and control BioPhase systems.

The BioPhase Instrument API provides programmatic access to instrument control and sequence execution functions, enabling remote monitoring, automated workflow execution, and integration with connected laboratory environments.

Yes. The BioPhase 8800 system can be integrated with laboratory scheduling, automation, orchestration, and robotic platforms through the BioPhase Instrument API.

Yes. The BioPhase Instrument API allows external software applications to remotely start, monitor, and stop BioPhase 8800 system sequence runs.

The BioPhase Instrument API provides access to project and sequence information, instrument status, workflow execution progress, and system monitoring information to support automated laboratory workflows.

The BioPhase Instrument API helps laboratories reduce manual intervention, automate workflow execution, monitor instrument performance, and connect BioPhase 8800 system workflows into broader laboratory automation ecosystems.